$NVCT

$18.49 -$1.56 (7.78%) Close

$NVCT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 32.6M shares outstanding

Who owns NVCT?

By type of holder

Institutions 30.4% Insiders 34.9% Everyone else 34.7%

Concentration Top 10 holders own 51.5%

Bentsur Ron 11.3% · Mosseri Marlio Charles 10.1%

Institutional ownership

30.4%

+16.8 pts vs last qtr

Institutional holders

+19 vs last qtr

Net shares bought

+5.5M

by institutions in Q2 2026

New / sold out

28 / 9

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Tang Capital Management LLC NEW +1.6M
Soleus Capital Management, L.P. NEW +1.0M

Biggest sellers in Q2 2026

Susquehanna International Group, LLP SOLD OUT −105.3K
Occam Crest Management LP −50.0K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Nuvectis Pharma Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+411.0%

+50.35% a year

Each share's claim on the business

−80.4%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $19.2M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years35% 1–3 years11% Under 1 year54%

Quarterly turnover

67.4%

of institutional shares changed hands

Top 10 managers, median time held

1.3 years

Super Investors

Investment managers reporting NVCT on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
TC Tang Capital Management LLC	1.6M	4.76%	NEW	Q2 '26	1.3%
Shares held by quarter Peak holding1.6M (Q2'26) Change over 8 quarters+1.6M Share of the company4.760% Tang Capital Management LLC's full portfolio →
B BlackRock, Inc.	1.0M	3.07%	+236.8K (+31.0%)	2022	0.0%
Shares held by quarter Peak holding1.0M (Q2'26) Change over 8 quarters+951.7K Share of the company3.070% BlackRock, Inc.'s full portfolio →

Tang Capital Management LLC

1.6M

% of company

4.76%

Change vs last qtr

NEW

Held since

Q2 '26

BlackRock, Inc.

1.0M

% of company

3.07%

Change vs last qtr

+236.8K (+31.0%)

Held since

2022

28 more super investors behind a free account

See every manager holding Nuvectis Pharma Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting NVCT on Form N-PORT; together they hold 6.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$8.87M	482.1K	1.48%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$7.92M	430.8K	1.32%	0.01%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$8.87M

% of company

1.48%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$7.92M

% of company

1.32%

% of the fund

0.01%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Nuvectis Pharma Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
BR Bentsur Ron Insider	3.7M	11.32%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company11.320% Bentsur Ron's insider activity →
MM Mosseri Marlio Charles Insider	3.3M	10.12%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company10.120% Mosseri Marlio Charles's insider activity →

Bentsur Ron

Insider

3.7M

% of company

11.32%

Change vs last qtr

—

Held since

—

Mosseri Marlio Charles

Insider

3.3M

% of company

10.12%

Change vs last qtr

—

Held since

—

7 more holders behind a free account

See every insider and 5%+ holder of Nuvectis Pharma Inc.

Comments